TrialSignal
Clinical trial intelligence report
Effect of Intranasal Vasopressin on Cooperative Behavior in Schizophrenia
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT04190004
Status
COMPLETED
Phase
NA
Sponsor
National Institute of Mental Health and Neuro Sciences, India
Executive brief
Investment-Ready Snapshot
This completed interventional study evaluated the effects of intranasal vasopressin on cooperative behavior in patients diagnosed with schizophrenia. The study involved a randomized, double-masked, crossover design with 30 participants, assessing behavioral performance in economic games.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT04190004
Indication
Schizophrenia
Modality
RNA therapy
Target
Cooperative behavior in schizophrenia
Intervention
Vasopressins, Placebo
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.